NCT01658033 2015-09-09
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients
Fudan University
Phase 2 Completed
Fudan University
Adherex Technologies, Inc.
Northwestern University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)